BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32532258)

  • 1. CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
    Lazaar AL; Miller BE; Donald AC; Keeley T; Ambery C; Russell J; Watz H; Tal-Singer R;
    Respir Res; 2020 Jun; 21(1):149. PubMed ID: 32532258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panax ginseng C.A Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trial.
    Xue CC; Shergis JL; Zhang AL; Worsnop C; Fong H; Story D; Da Costa C; Thien FC
    Trials; 2011 Jun; 12():164. PubMed ID: 21718484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.
    Calverley PMA; Sethi S; Dawson M; Ward CK; Finch DK; Penney M; Newbold P; van der Merwe R
    Respir Res; 2017 Aug; 18(1):153. PubMed ID: 28793896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial.
    Zhang H; Li J; Yu X; Li S; Wang H; Ruan H; Si Y; Xie Y; Wang M
    Trials; 2019 Dec; 20(1):735. PubMed ID: 31842969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx.
    Sciurba FC; Dransfield MT; Kim V; Marchetti N; Comellas A; Hogarth DK; Majid A
    BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38151258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2.
    Valipour A; Shah PL; Herth FJ; Pison C; Schumann C; Hübner RH; Bonta PI; Kessler R; Gesierich W; Darwiche K; Lamprecht B; Perez T; Skowasch D; Deslee G; Marceau A; Sciurba FC; Gosens R; Hartman JE; Conway F; Duller M; Mayse M; Norman HS; Slebos DJ;
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2807-2816. PubMed ID: 33177818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study.
    Pragman AA; Fieberg AM; Reilly CS; Wendt C
    BMJ Open; 2021 Dec; 11(12):e050271. PubMed ID: 34903538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
    Tesfaigzi Y; Meek P; Lareau S
    Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores.
    Jones PW; Tabberer M; Chen WH
    BMC Pulm Med; 2011 Aug; 11():42. PubMed ID: 21835018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putting health status guided COPD management to the test: protocol of the MARCH study.
    Kocks J; de Jong C; Berger MY; Kerstjens HA; van der Molen T
    BMC Pulm Med; 2013 Jul; 13():41. PubMed ID: 23826685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of N-Acetylcysteine for Chronic Obstructive Pulmonary Disease and Chronic Bronchitis.
    Zhang L; Xiong Y; Du L
    Biomed Res Int; 2022; 2022():9133777. PubMed ID: 35795313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial.
    Valipour A; Fernandez-Bussy S; Ing AJ; Steinfort DP; Snell GI; Williamson JP; Saghaie T; Irving LB; Dabscheck EJ; Krimsky WS; Waldstreicher J
    Am J Respir Crit Care Med; 2020 Sep; 202(5):681-689. PubMed ID: 32407638
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.
    Nie G; Cao X; Mao Y; Lv Z; Lv M; Wang Y; Wang H; Liu C
    Int Immunopharmacol; 2021 Jun; 95():107153. PubMed ID: 33677254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.
    Yan X; Song Y; Shen C; Xu W; Chen L; Zhang J; Liu H; Huang M; Lai G; Qian G; Wang J; Ye X; Zheng J; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():803-812. PubMed ID: 28405161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in molecular mechanism and treatment of chronic mucus hypersecretion].
    Yue XT; Zou XY; Zhu GL; Chen DH; Dong YC; Han YP; Zhang JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1272-1278. PubMed ID: 38044058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Inflammation-on-a-Chip with a Complete 3D Interface: Pharmacological Applications in COPD-Induced Neutrophil Migration.
    Kim S; Lee SK; Son A; Lee JH; Kim HG
    Adv Healthc Mater; 2023 Dec; 12(30):e2301673. PubMed ID: 37505448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway-occluding Mucus Plugs and Cause-specific Mortality in Chronic Obstructive Pulmonary Disease.
    Mettler SK; Sonavane S; Grumley S; Nath HP; Yen AC; Pistenmaa C; Nardelli P; San Jose Estepar R; Cho MH; Diaz AA
    Am J Respir Crit Care Med; 2024 Jun; 209(12):1508-1510. PubMed ID: 38771048
    [No Abstract]   [Full Text] [Related]  

  • 18. CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin.
    Keir HR; Richardson H; Fillmore C; Shoemark A; Lazaar AL; Miller BE; Tal-Singer R; Chalmers JD; Mohan D
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263062
    [No Abstract]   [Full Text] [Related]  

  • 19. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
    Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
    Rabe KF; Martinez FJ; Ferguson GT; Wang C; Singh D; Wedzicha JA; Trivedi R; St Rose E; Ballal S; McLaren J; Darken P; Aurivillius M; Reisner C; Dorinsky P;
    N Engl J Med; 2020 Jul; 383(1):35-48. PubMed ID: 32579807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.